The Participation of Cytochrome P450 3A4 in Clozapine Biotransformation Is Detected in People With Schizophrenia by High-Throughput In Vivo Phenotyping

被引：5
|
作者：
Ghassabian, Sussan [1 ]
Chetty, Manoranjenni [1 ]
Tattam, Bruce N. [1 ]
Glen, John [2 ]
Rahme, Jeannie [2 ]
Stankovic, Zvijezdana [2 ]
Ramzan, Iqbal [1 ]
Murray, Michael [1 ]
McLachlan, Andrew J. [1 ,3 ]
机构：
[1] Univ Sydney, Fac Pharm, Camperdown, NSW, Australia
[2] Macquarie Hosp, N Ryde, NSW, Australia
[3] Concord Hosp, Ctr Educ & Res Ageing, Concord, NSW, Australia
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2010年 / 30卷 / 05期
关键词：
CYP1A2; ACTIVITY; METABOLISM; ISOFORMS;
D O I：
10.1097/JCP.0b013e3181f03e30
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：629 / 631
页数：3
相关论文
共 50 条
  • [1] High-throughput fluorescence assay of cytochrome P450 3A4
    Cheng, Qian
    Sohl, Christal D.
    Guengerich, F. Peter
    NATURE PROTOCOLS, 2009, 4 (09) : 1258 - 1261
  • [2] High-throughput fluorescence assay of cytochrome P450 3A4
    Qian Cheng
    Christal D Sohl
    F Peter Guengerich
    Nature Protocols, 2009, 4 : 1258 - 1261
  • [3] Biotransformation of zafirlukast by cytochrome P450 3A4
    Skordos, KW
    Yost, GS
    DRUG METABOLISM REVIEWS, 2003, 35 : 49 - 49
  • [4] Development of a high-throughput cytochrome P450 3A4 time-dependent inhibition assay
    Tai, EHL
    Liu, LL
    Van Natta, K
    DRUG METABOLISM REVIEWS, 2004, 36 : 288 - 288
  • [5] Structures of cytochrome P450 3A4
    Scott, EE
    Halpert, JR
    TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (01) : 5 - 7
  • [6] High-throughput approaches to the quantitative analysis of ketoconazole, a potent inhibitor of cytochrome P450 3A4, in human plasma
    Ramos, L.
    Brignol, N.
    Bakhtiar, R.
    Ray, T.
    Mc Mahon, L.M.
    Tse, F.L.S.
    2000, John Wiley and Sons Ltd (14)
  • [7] High-throughput approaches to the quantitative analysis of ketoconazole, a potent inhibitor of cytochrome P450 3A4, in human plasma
    Ramos, L
    Brignol, N
    Bakhtiar, R
    Ray, T
    McMahon, LM
    Tse, FLS
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2000, 14 (23) : 2282 - 2293
  • [8] Development and use of an in-vivo phenotyping test for cytochrome P450 3A4 in cancer patients.
    Brown, SJ
    Ward, CY
    Wolf, RC
    Rankin, EM
    BRITISH JOURNAL OF CANCER, 2003, 88 : S33 - S33
  • [9] Prediction of irinotecan pharmacokinetics by use of cytochrome p450 3A4 phenotyping probes
    Mathijssen, RHJ
    de Jong, FA
    van Schaik, RHN
    Lepper, ER
    Friberg, LE
    Rietveld, T
    de Bruijn, P
    Graveland, WJ
    Figg, WD
    Verweij, J
    Sparreboom, A
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (21): : 1585 - 1592
  • [10] Molecular modeling of cytochrome P450 3A4
    Szklarz, GD
    Halpert, JR
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1997, 11 (03) : 265 - 272
12345